You are here

Our science / Clinical Trials / Find a Trial / NCT00366262

Study Evaluating the Gastrointestinal Safety of PLA-695 Compared to Placebo and Naproxen

Back to Search Print Save as PDF Bookmark Trial

NCT00366262

Last updated on March 14, 2019
Back to Search Print Save as PDF Bookmark Trial

FOR MORE INFORMATION
Study Location
Houston, Texas, 77074 United States
See other locations
Contact
1-800-718-1021
[email protected]
Related Links
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Healthy
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-60 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Healthy men or women of nonchildbearing potential, aged 18 to 60 years.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Abnormal baseline endoscopy.

- Positive Helicobacter pylori serology.

NCT00366262
Pfizer
Completed
Study Evaluating the Gastrointestinal Safety of PLA-695 Compared to Placebo and Naproxen

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Advanced Search

Based on your search, you may also be interested in

Healthy Volunteers
Evaluate Taste and Relative Bioavailability of Two Microsphere Formulations of Crizotinib in Healthy Participants
NCT03978143
All Genders
18+
Years
New Haven, Connecticut
Healthy Volunteers
Study to Characterize Absorption, Distribution, Metabolism and Excretion of 14C PF-06651600 and to Evaluate the Absolute Oral Bioavailability and Fraction Absorbed of PF-06651600.
NCT03929510
Males
18+
Years
Multiple Sites
Healthy
Singe Dose Study of PF- 06946860 in Healthy Adult Japanese Participants
NCT03974776
All Genders
18+
Years
Anaheim, California
Healthy
A Study to Assess Pharmacokinetics of PF-04965842 and Its Metabolites and Effect of Probenecid in Healthy Participants
NCT03937258
All Genders
18+
Years
New Haven, Connecticut

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now